21 reports

  • LEADING COMPANIES

One third of all new cancer cases globally occur in China.

  • Pharmaceutical
  • Therapy
  • Apotex Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • LEADING COMPANIES

It is one of the world' s best locations in terms of innovating securely, with Germany' s legal system one of the world' s most efficient and independent.

  • Pharmaceutical
  • Therapy
  • Apotex Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Corporate Analysis

It is one of the leading and fasting growing companies.

  • Pharmaceutical
  • Therapy
  • Allergan plc
  • Apotex Inc.
  • Mylan Inc.
  • LEADING COMPANIES

Almirall operates in one segment: pharmaceuticals.

  • Pharmaceutical
  • Therapy
  • Apotex Inc.
  • Boehringer Ingelheim GmbH
  • Daiichi Sankyo Company
  • LEADING COMPANIES

AstraZeneca has one business segment: biopharmaceuticals.

  • Pharmaceutical
  • Therapy
  • Apotex Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Corporate Analysis
  • HATCH-WAXMAN ACT AND PARAGRAPH IV CERTIFICATIONS

One of the problems faced by pharmaceutical companies is that pharmaceutical sales representatives familiar with one therapy area find it difficult to switch to another.

  • Pharmaceutical
  • Therapy
  • Apotex Inc.
  • Mylan Inc.
  • Teva Pharmaceutical Industries Ltd.
  • pegfilgrastim

TS-## (tegafur, gimeracil, oteracil) ##.

  • Colony Stimulating Factor
  • Monoclonal Antibody
  • Therapy
  • Amgen Inc.
  • Apotex Inc.
  • Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Therapeutics Development
  • PIPELINE BY GENERVON BIOPHARMACEUTICALS LLC, H2 2019

The ## pathways are as follows: ##.

  • Antimalarials
  • Dementia
  • Therapy
  • World
  • Genervon Biopharmaceuticals, LLC
  • MAY 23, 2016: ALS PATIENTS FROM AROUND THE WORLD RESPONDING WELL TO GENERVONS GM604
  • PIPELINE BY GENERVON BIOPHARMACEUTICALS LLC, H2 2019

The ## pathways are as follows: ##.

  • Therapy
  • United States
  • World
  • Product Initiative
  • Genervon Biopharmaceuticals, LLC
  • Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Therapeutics Development
  • PIPELINE BY GENERVON BIOPHARMACEUTICALS LLC, H1 2019

The ## pathways are as follows: ##.

  • Antimalarials
  • Dementia
  • Therapy
  • World
  • Genervon Biopharmaceuticals, LLC
  • MAY 23, 2016: ALS PATIENTS FROM AROUND THE WORLD RESPONDING WELL TO GENERVONS GM604
  • PIPELINE BY GENERVON BIOPHARMACEUTICALS LLC, H1 2019

The ## pathways are as follows: ##.

  • Therapy
  • United States
  • World
  • Product Initiative
  • Genervon Biopharmaceuticals, LLC
  • Apoptosis Regulator BAX (Bcl 2 Like Protein 4 or BCL2L4 or BAX) - Companies Involved in Therapeutics Development
  • MAY 23, 2016: ALS PATIENTS FROM AROUND THE WORLD RESPONDING WELL TO GENERVONS GM604

SMBA-## - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description SMBA-## Emory University NA NA SMBA-## is under investigation for the treatment of lung cancer.

  • Dementia
  • Therapy
  • United States
  • Product Initiative
  • Genervon Biopharmaceuticals, LLC
  • MAY 23, 2016: ALS PATIENTS FROM AROUND THE WORLD RESPONDING WELL TO GENERVON'S GM604
  • The Company also announced that it is planning the next trial for GM604.

SMBA-## - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description SMBA-## Emory University NA NA SMBA-## is under investigation for the treatment of lung cancer.

  • Therapy
  • United States
  • World
  • Product Initiative
  • Genervon Biopharmaceuticals, LLC
  • MAY 23, 2016: ALS PATIENTS FROM AROUND THE WORLD RESPONDING WELL TO GENERVONS GM604
  • JUN 30, 2014: GENERVON ANNOUNCES BIOMARKER DATA FROM GALS-001 CLINICAL TRIAL FOR ALS

The ## pathways are as follows: ##.

  • Therapy
  • United States
  • World
  • Product Initiative
  • Genervon Biopharmaceuticals, LLC
  • Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Therapeutics Development
  • PIPELINE BY GENERVON BIOPHARMACEUTICALS LLC, H2 2018

The ## pathways are as follows: ##.

  • Antimalarials
  • Dementia
  • Therapy
  • Product Initiative
  • Genervon Biopharmaceuticals, LLC

This makes the market an attractive one for potential new entrants.

  • Pharmaceutical
  • Therapy
  • Allergan plc
  • Apotex Inc.
  • Aspen Pharmacare Holdings Limited
  • Biomarker Data
  • JAN 08, 2015: GENERVON ANNOUNCES ALS COMPASSIONATE USE RESULTS

SMBA-## - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description SMBA-## Emory University NA NA SMBA-## is under investigation for the treatment of lung cancer.

  • Therapy
  • United States
  • World
  • Product Initiative
  • Genervon Biopharmaceuticals, LLC
  • MAY 23, 2016: ALS PATIENTS FROM AROUND THE WORLD RESPONDING WELL TO GENERVONS GM604
  • JUN 30, 2014: GENERVON ANNOUNCES BIOMARKER DATA FROM GALS-001 CLINICAL TRIAL FOR ALS

The ## pathways are as follows: ##.

  • Dementia
  • Therapy
  • United States
  • Product Initiative
  • Genervon Biopharmaceuticals, LLC
  • Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Therapeutics Development
  • The Company also announced that it is planning the next trial for GM604.

The ## pathways are as follows: ##.

  • Dementia
  • Therapy
  • United States
  • Product Initiative
  • Genervon Biopharmaceuticals, LLC
  • PARTNERSHIP - DEAL REPORTS

It is headquartered in PARTNER ##: MYLAN N. V.

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Therapy
  • Apotex Inc.
  • PARTNERSHIP - DEAL REPORTS

It is headquartered in PARTNER ##: MYLAN N. V.

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Therapy
  • Apotex Inc.